Interv Akut Kardiol. 2017;16(3):116-118 | DOI: 10.36290/kar.2017.032
The future of bioresorbable stents
- Kardiologické centrum Agel, Pardubice
Review of the current development in the field of bioresorbable stents.
Keywords: very late stent thrombosis, bioresorbable stent
Published: November 1, 2017 Show citation
References
- Raber L, Magro M, Stefanini GG. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospecitve cohort study. Circulation 2012; 125: 1110-1121.
Go to original source... 
Go to PubMed... - Serruys PW, Daemen J. Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115: 1433-1439. Go to original source... Go to PubMed...
- Holmes DR, Keraiakes DJ, Garg S. Stent thrombosis. J Am Coll Cardiol 2010; 56: 1357-1365. Go to original source... Go to PubMed...
- Palmerini T, Biondi-Zoccai G, Della Riva D. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2014; 63: 299-307. Go to original source... Go to PubMed...
- Garot P, Morice MC, Tresukosol D. 2-year Outcomes of high bleeding risk patients after polymerfree drug-coated stents. J Am Coll Cardiol 2017; 69: 162-171. Go to original source... Go to PubMed...
- Waksman R, Erbel R, Di Mario C. PROGRESS-AMS: Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv 2009; 2: 312-320. Go to original source... Go to PubMed...
- Rizik DG, Hermiller JB, Simonton CA. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials? Coron Artery Dis 2017; 28: 77-89. Go to original source... Go to PubMed...
- Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol 2014; 64: 2541-2551. Go to original source... Go to PubMed...
- Tenekecioglu E, Farooq V, Bourantas CV. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovsc Disord 2016; 16: 38-49. Go to original source... Go to PubMed...
- Cheng Y, Gasior P, Xia JG. Comparative biomechanical behavior and healing profile of a novel thinned wall ultrahigh molecular weight amorphous PLLA sirolimus-eluting bioresorbable coronary scaffold. Circ Cardiovasc Interv 2017; 10: pii: e005116. Go to original source... Go to PubMed...
- Haude M, Ince H, Abizaid A. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. Eur Heart J 2016; 37: 2701-2709. Go to original source... Go to PubMed...
- Frattolin J, Barua R, Aydin H. Development of a novel biodegradable metallic stent based on microgalvanic effect. Ann Biomed Eng 2016; 44: 404-418. Go to original source... Go to PubMed...
- Huang T, Cheng J, Zheng YF. In vitro degradation and biocompatibility of Fe-Pd and Fe-Pt composites fabricated by spark plasma sintering. Mater Sci Eng C Mater Biol Appl 2014; 35: 43-53. Go to original source... Go to PubMed...
- Drynda A Hassel T, Bach FW. In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications. J Biomed Mater Res B Appl Biomater 2015; 103: 649-660. Go to original source... Go to PubMed...